Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models

被引：0
|
作者：
Franklin, M. [1 ]
Thayer, M. [2 ]
Draper, D. [2 ]
Saims, D. [2 ]
Wise, S. [2 ]
机构：
[1] Mi Biores, Sci Dev, Ann Arbor, MI USA
[2] Mi Biores, Operat, Ann Arbor, MI USA
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32887-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [21] MicroRNAs and Tumor Vasculature Normalization: Impact on Anti-Tumor Immune Response
    Agata Matejuk
    Guillaume Collet
    Mahdi Nadim
    Catherine Grillon
    Claudine Kieda
    Archivum Immunologiae et Therapiae Experimentalis, 2013, 61 : 285 - 299
  • [22] NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
    Selvanesan, Benson Chellakkan
    Pulido, Alvaro de Mingo
    Varghese, Sheelu
    Rohila, Deepak
    Hupalo, Daniel
    Gusev, Yuriy
    Contente, Sara
    Wilkerson, Matthew D.
    Dalgard, Clifton L.
    Upadhyay, Geeta
    CANCERS, 2023, 15 (05)
  • [23] Combination of a Novel EP4 Antagonist E7046 and Radiation Therapy Promotes Anti-tumor Immune Response and Tumor Rejection in Preclinical Tumor Models
    Bao, X.
    Albu, D. I.
    Huang, K. C.
    Wu, J.
    Twine, N.
    Nomoto, K.
    Woodall-Jappe, M.
    Ataman, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S128 - S128
  • [24] Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model
    Ishida, Eiichi
    Lee, Jina
    Campbell, Jean S.
    Chakravarty, Patrick D.
    Katori, Yukio
    Ogawa, Takenori
    Johnson, Lauren
    Mukhopadhyay, Anandaroop
    Faquin, William C.
    Ling, Derrick T.
    Wirth, Lori J.
    Pierce, Robert H.
    Pai, Sara, I
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (08) : 1273 - 1286
  • [25] Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model
    Eiichi Ishida
    Jina Lee
    Jean S. Campbell
    Patrick D. Chakravarty
    Yukio Katori
    Takenori Ogawa
    Lauren Johnson
    Anandaroop Mukhopadhyay
    William C. Faquin
    Derrick T. Lin
    Lori J. Wirth
    Robert H. Pierce
    Sara I. Pai
    Cancer Immunology, Immunotherapy, 2019, 68 : 1273 - 1286
  • [26] TAK-243 increases tumor immunogenicity enhancing systemic anti-tumor immune response and tumor regression in combination with immune checkpoint inhibition in a syngeneic model of lymphoma
    Klinghoffer, Richard
    Burns, Connor
    Merrell, Angela
    Grenley, Marc
    CANCER RESEARCH, 2023, 83 (07)
  • [27] ANTI-TUMOR EFFECT OF SYNGENEIC SPLEEN-CELLS TREATED WITH IMMUNE RNA AND TUMOR-ANTIGEN
    FUKUSHIMA, M
    COLMERAUER, MEM
    NAYAK, SK
    KOZIOL, JA
    PILCH, YH
    INTERNATIONAL JOURNAL OF CANCER, 1982, 29 (01) : 113 - 117
  • [28] The tyrosine kinase inhibitor XL092 promotes an immune-permissive tumor microenvironment and enhances the anti-tumor activity of immune checkpoint inhibitors in preclinical models
    Hsu, Jeff
    Chong, Colin
    Serrill, Jeffrey
    Wu, Sharon
    Leong, Kevin
    Yun, Ted
    Bannen, Lynne
    Lamb, Peter
    Xu, Wei
    Yu, Peiwen
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [29] PASSIVE IMMUNOTHERAPY WITH SYNGENEIC ANTI-TUMOR SERUM - PASSIVE IMMUNOTHERAPY OF ESTABLISHED TUMORS WITH SYNGENEIC ANTI-TUMOR SERUM IN COMBINATION WITH IMMUNOPOTENTIATORS
    SHINODA, H
    YAMAZAKI, M
    MIZUNO, D
    GANN, 1977, 68 (05): : 567 - 571
  • [30] B cell regulation of anti-tumor immune response
    Zhang, Yu
    Morgan, Richard
    Podack, Eckhard R.
    Rosenblatt, Joseph
    IMMUNOLOGIC RESEARCH, 2013, 57 (1-3) : 115 - 124
12345